2026 News + Events

Visit IntraOp at ASTRO 2026 in Boston!

IntraOp is excited to be exhibiting at ASTRO 2026, September 27–29 in Boston. Visit us at Booth #1420 to discover how IntraOp is advancing electron radiotherapy across a growing range of clinical and research applications. From pioneering electron FLASH radiotherapy to expanding access to intraoperative electron radiation therapy (IOERT) and electron beam radiation therapy (EBRT) … Continued

Read More

IntraOp Medical Corporation Celebrates 1,000th Patient Treated with the Mobetron at Salzburg University Hospital

IntraOp Medical Corporation Celebrates 1,000th Patient Treated with the Mobetron at Salzburg University Hospital Salzburg Team Continues to Advance Image-Guided Intraoperative Radiation Therapy and Personalized Cancer Care Left to right: Dipl. Ing. Dr. Christoph Gaisberger, Dr. Markus Stana, MSc, Sandra Pfeiffer, Manfred Weissbacher, Priv.-Doz. Dr. Brane Grambozov, Univ.-Prof. Dr. Falk Röder Courtesy of Uniklinikum Salzburg … Continued

Read More

Visit IntraOp at AAPM 2026 – Booth #1111

IntraOp Medical is excited to exhibit at the AAPM | COMP Annual Meeting & Exhibition, July 19–21, 2026, in Vancouver, British Columbia. Visit us at Booth #1111 to learn why IntraOp is leading the advancement of electron FLASH radiotherapy and how we’re helping shape the future of ultra-high dose rate electron therapy. Whether you’re exploring … Continued

Read More

IntraOp Medical Corporation at ESTRO 2026 in Stockholm

IntraOp Medical Corporation is pleased to announce its participation as an exhibitor at the European Society for Radiotherapy and Oncology (ESTRO) Annual Congress 2026, taking place May 15–19, 2026, in Stockholm, Sweden. At ESTRO 2026, IntraOp will showcase the latest advancements in FLASH radiotherapy, with a focus on ongoing and emerging clinical trial progress involving … Continued

Read More

IntraOp Medical Announces Completion of Pioneering Human FLASH Radiotherapy Trial and Publication of Landmark Clinical & Physics Results with Lausanne University Hospital (CHUV)

Fremont, CA – 03/26/2026 – IntraOp Medical Corporation today announced the successful completion of the IMPulse Trial, the world’s first human dose escalation study of single fraction FLASH radiotherapy (FLASH RT) for cutaneous melanoma metastases. The findings, together with a companion physics and dosimetry study, were conducted in collaboration with Lausanne University Hospital (CHUV) using … Continued

Read More